Expression of the antiapoptotic proteins clusterin and Bcl-2 in laryngeal squamous cell carcinomas

Tumor Biology

Volumn 27, Issue 4, 2006, Pages 195-200

  Redondo, Maximino ^a,e   Esteban, Francisco ^b   González Moles, Miguel A ^b   Delgado Rodríguez, Miguel ^c   Nevado, Manuel ^b   Torres Muñoz, Jorge E ^d   Tellez, Teresa ^a   Villar, Eduardo ^a   Morell, Miguel ^a   Petito, Carol K ^d  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^c UNIVERSITY OF JAÉN   (Spain)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e HOSPITAL COSTA DEL SOL   (Spain)

Author keywords

Bcl 2; Clusterin; Laryngeal cancer

Indexed keywords

APOPTOSIS INHIBITOR; CLUSTERIN; MESSENGER RNA; PROTEIN BCL 2;

ADULT; AGED; ARTICLE; CANCER INVASION; GENE EXPRESSION REGULATION; GLOTTIS; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE;

EID: 33646735747     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093055     Document Type: Article

References (33)

1. Haldar S, Jena N, Croce CM: Antiapoptosis potential of bcl-2 oncogene by dephosphorylation. Biochem Cell Biol 1994;72:455-462.
2. Zhang H, Kim JK, Edwards CA, Xu Z, Taichman R, Wang CY: Clusterin inhibits apoptosis by interacting with activated bax. Nat Cell Biol 2005;7:909-915.
3. Trougakos IP, Gonos ES: Clusterin/apolipoprotein J in human aging and cancer. Int J Biochem Cell Biol 2002;34:1430-1448.
4. Steinberg J, Oyasu R, Lang S, Sintich S, Rademaker A, Lee C, Kozlowski JM, Sensibar JA: Intracellular levels of SGP-2 (clusterin) correlate with tumor grade in prostate cancer. Clin Cancer Res 1997;3:1707-1711.
5. Redondo M, Villar E, Torres JE, Tellez T, Morell M, Petito CK: Overexpression of clusterin in human breast carcinoma. Am J Pathol 2000;157:393-399.
6. Chen X, Halberg RB, Ehrhardt WM, Torrealba J, Dove WF: Clusterin as a biomarker in murine and human intestinal neoplasia. Proc Natl Acad Sci USA 2003;100:9530-9535.
7. Gleave M, Miyake H: Use of antisense oligonucleotides target in the cytoprotective gene, clusterin, to enhance androgen- and chemosensitivity in prostate cancer. World J Urol 2005;23:38-46.
8. Yuen AP, Lam KY, Choy JT, Ho WK, Wei WI: The clinicopathological significance of bcl-2 expression in the surgical treatment of laryngeal carcinoma. Clin Otolaryngol 2001;26:129-133.
9. Fracchiolla NS, Capaccio P, Carboni N, Pagliari AV, Neri A, Ronchett D, Pruner G, Silvotti MG, Pignataro L, Buffa R, Broich G: Immunohistochemical and molecular analysis of bax, bcl-2 and p53 genes in laryngeal squamous cell carcinomas. Anticancer Res 1999;19:1043-1052.
10. Jackel MC, Dorudian MA, Marx D, Brinck U, Schauer A, Steiner W: Spontaneous apoptosis in laryngeal squamous cell carcinoma is independent of bcl-2 and bax protein expression. Cancer 1999;85:591-599.
11. Villar E, Redondo M, Rodrigo I, Garcia J, Avila E, Matilla A: The clinical significance of bcl-2 expression and apoptosis in primary and metastatic breast carcinomas. Tumor Biol 2001;22:137-145.
12. Gasparini G, Barbareschi M, Doglioni C, Palma PD, Mauri FA, Boracchi P, Bevilacqua P, Caffo O, Morelli L, Verderio P: Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer. Clin Cancer Res 1995;1:189-198.
13. Pezzella F, Turley H, Kuzu I, Tungekar MF, Dunnill MS, Pierce CB, Harris A, Gatter KC, Mason DY: bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med 1993;329:690-694.
14. Krajewska M, Krajewski S, Epstein JI, Shabaik A, Sauvageot J, Song K, Kitada S, Reed JC: Immunohistochemical analysis of bcl-2, bax, bcl-x, and mcl-1 expression in prostate cancers. Am J Pathol 1996;148:1567-1576.
15. Karamitopoulou E, Perentes E, Tolnay M, Probst A: Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas. Hum Pathol 1998;29:140-145.
16. Hirvikoski P, Kumpulainen E, Virtaniemi J, Pirinen R, Salmi L, Halonen P, Johansson R, Kosma VM: Enhanced apoptosis correlates with poor survival in patients with laryngeal cancer but not with cell proliferation, bcl-2 or p53 expression. Eur J Cancer 1999;35:231-237.
17. Glanz H: Carcinoma of the larynx. Growth, p-classification and grading of squamous cell carcinoma of the vocal cords. Adv Otorhinolaryngol 1984;32:1-123.
18. Langlois NE, Lamb J, Eremin O, Heys SD: Apoptosis in colorectal carcinoma occurring in patients aged 45 years and under: relationship to prognosis, mitosis, and immunohistochemical demonstration of p53, c-myc and bcl-2 protein products. J Pathol 1997;182:392-397.
19. Torres JE, Redondo M, Czeisler C, Czeisler C, Roberts B, Tacoronte N, Petito CK: Up-regulation of glial clusterin in brains of patients with AIDS. Brain Res 2001;888:297-301.
20. Lu QL, Abel P, Foster CS, Lalani EN: Bcl-2: role in epithelial differentiation and oncogenesis. Hum Pathol 1996;27:102-110.
21. Bettuzzi S, Scorcioni F, Astancolle S, Davalli P, Scaltriti M, Corti A: Clusterin (SGP-2) transient overexpression decreases proliferation rate of SV40-immortalized human prostate epithelial cells by slowing down cell cycle progression. Oncogene 2002;21:4328-4334.
22. McDonnell TJ, Troncoso P, Brisbay SM, Logothetis C, Chung LW, Hsieh JT, Tu SM, Campbell ML: Expression of the proto-oncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 1992;52:6940-6944.
23. Hara I, Miyake H, Gleave ME, Kamidono S: Introduction of clusterin gene into human renal cell carcinoma cells enhances their resistance to cytotoxic chemotherapy through inhibition of apoptosis both in vitro and in vivo. Jpn J Cancer Res 2001;92:1220-1224.
24. Trask DK, Wolf GT, Bradford CR, Fisher SG, Devaney K, Johnson M, Singleton T, Wicha M: Expression of Bcl-2 family proteins in advanced laryngeal squamous cell carcinoma: correlation with response to chemotherapy and organ preservation. Laryngoscope 2002;112:638-644.
25. Whisler LC, Wood NB, Caldarelli DD, Hutchinson JC, Panje WR, Friedman M, Preisler HD, Leurgans S, Nowak J, Coon JS: Regulators of proliferation and apoptosis in carcinoma of the larynx. Laryngoscope 1998;108:630-638.
26. Xie X, Clausen O, De Angelis P, Boysen M: The prognostic value of spontaneous apoptosis, bax, bcl-2, and p53 in oral squamous cell carcinoma of the tongue. Cancer 1999;86:913-920.
27. Wilson GD, Grover R, Richman PI, Daley FM, Saunders MI, Dische S: Bcl-2 expression correlates with favourable outcome in head and neck cancer treated by accelerated radiotherapy. Anticancer Res 1996;16:2403-2408.
28. Homma A, Furuta Y, Oridate N, Nakano Y, Yagi K, Nagahashi T, Fukuda S, Inuyama Y: Correlation of clinicopathological parameters and biological markers related to apoptosis and proliferative activity with a clinical outcome in squamous cell carcinoma of the larynx treated with concurrent chemoradiotherapy. Auris Nasus Larynx 2001;28(suppl):S87-S94.
29. Friedman M, Lim JW, Manders E, Schaffner AD, Kirshenbaum GL, Tanyeri HM, Caldarelli DD, Coon JS: Prognostic significance of Bcl-2 and p53 expression in advanced laryngeal squamous cell carcinoma. Head Neck 2001;23:280-285.
30. Pena JC, Thompson CB, Recant W, Vokes EE, Rudin CM: Bcl-xl and bcl-2 expression in squamous cell carcinoma of the head and neck. Cancer 1999;85:164-170.
31. Zellweger T, Miyake H, Cooper S, Chi K, Conklin BS, Monia BP, Gleave ME: Antitumor activity of antisense clusterin oligonucleotides is improved in vitro and in vivo by incorporation of 2′-O-(2-methoxy)ethyl chemistry. J Pharmacol Exp Ther 2001;298:934-940.
32. Trougakos IP, So A, Jansen B, Gleave ME, Gonos ES: Silencing expression of the clusterin/apolipoprotein j gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress. Cancer Res 2004;64:1834-1842.
33. Pasinetti GM, Johnson SA, Oda T, Rozovsky I, Finch CE: Clusterin (SGP-2): a multifunctional glycoprotein with regional expression in astrocytes and neurons of the adult rat brain. J Comp Neurol 1994;339:387-400.